NeuroLight

Country:
USA
Founding year:
2017

NeuroLight is a neurotechnology company developing non-invasive neuromodulation technologies focused on brain entrainment and neuroenhancement. The company aims to enable controlled induction of specific brain states to support wellbeing, performance, and altered states of consciousness.

Its patented technology uses coordinated light and sound stimulation to modulate neural activity and replicate predefined brain states in a recipient. This approach, described as brain state transplantation, is designed to induce states such as sleep, flow, hyper-focus, relaxation, and other altered or optimized cognitive states without invasive intervention.

NeuroLight’s technology is positioned for use in wellness, performance, and experimental neuroenhancement contexts rather than clinical diagnostics or implanted therapies. The company frames its platform as an applied neuromodulation system that leverages sensory stimulation to influence brain dynamics in a controlled and repeatable manner.

Neuromodulation
Wellness
Experimental

Neurofounders Insights

Modality:
Light/sound
Form Factor:
Headset/cap
Interface Depth:
Non-invasive
Indication:
Sleep
Target user:
Patients
Regulatory stage:
Investigational

Non-dilutive

NeuroLight sits in the brain-state induction segment, using light and sound stimulation to drive targeted cognitive or sleep-related states. It remains closer to wellness and experimental self-regulation than to regulated neuromodulation therapy.

Related companies

Articles featuring

NeuroLight

No articles yet!

Press releases

No press releases published yet.